Most Recent Links

Follow us on Facebook and Twitter, or subscribe to our mailing list, to receive news updates. Learn more.


Links 1 - 20 of 22356

Sarah Boseley Health editor A single dose of psilocybin, the active ingredient of magic mushrooms, can lift the anxiety and depression experienced by people with advanced cancer for six months or even longer, two new studies show. Researchers involved in the two trials in the United States say the results are remarkable. The volunteers had “profoundly meaningful and spiritual experiences” which made most of them rethink life and death, ended their despair and brought about lasting improvement in the quality of their lives. The results of the research are published in the Journal of Psychopharmacology together with no less than ten commentaries from leading scientists in the fields of psychiatry and palliative care, who all back further research. While the effects of magic mushrooms have been of interest to psychiatry since the 1950s, the classification of all psychedelics in the US as schedule 1 drugs in the 1970s, in the wake of the Vietnam war and the rise of recreational drug use in the hippy counter-culture, has erected daunting legal and financial obstacles to running trials. “I think it is a big deal both in terms of the findings and in terms of the history and what it represents. It was part of psychiatry and vanished and now it’s been brought back,” said Dr Stephen Ross, director of addiction psychiatry at NYU Langone Medical Center and lead investigator of the study that was based there. © 2016 Guardian News and Media Limited

Keyword: Depression; Drug Abuse
Link ID: 22940 - Posted: 12.01.2016

By BENEDICT CAREY The same digital screens that have helped nurture a generation of insomniacs can also help restore regular sleep, researchers reported on Wednesday. In a new study, more than half of chronic insomniacs who used an automated online therapy program reported improvement within weeks and were sleeping normally a year later. The new report, published in the journal JAMA Psychiatry, is the most comprehensive to date suggesting that many garden-variety insomniacs could benefit from the gold standard treatment — cognitive behavior therapy — without ever having to talk to a therapist. At least one in 10 adults has diagnosable insomnia, which is defined as broken, irregular, inadequate slumber at least three nights a week for three months running or longer. “I’ve been an insomniac all my life, I’ve tried about everything,” said Dale Love-Callon, 70, a math tutor living in Rancho Palos Verdes, Calif., who recently used the software. “I don’t have it 100 percent conquered, but I’m sleeping much better now.” Previous studies have found that online sleep therapy can be effective, but most have been smaller, or focused on a particular sleep-related problem, like depression. The new trial tested the digital therapy in a broad, diverse group of longtime insomniacs whose main complaint was lack of sleep. Most had used medication or supplements over the years, and some still did. “These results suggest that there are a group of patients who can benefit without the need of a high-intensity intervention,” like face-to-face therapy, said Jack Edinger, a professor in the department of medicine at National Jewish Health in Denver, who was not a part of the study. “We don’t know yet exactly who they are — the people who volunteer for a study like this in first place are self-motivated — but they’re out there.” © 2016 The New York Times Company

Keyword: Sleep
Link ID: 22939 - Posted: 12.01.2016

By Clare Wilson WE HAVE been thinking about Parkinson’s disease all wrong. The condition may arise from damage to the gut, not the brain. If the idea is correct, it opens the door to new ways of treating the disease before symptoms occur. “That would be game-changing,” says David Burn at Newcastle University, UK. “There are lots of different mechanisms that could potentially stop the spread.” Parkinson’s disease involves the death of neurons deep within the brain, causing tremors, stiffness and difficulty moving. While there are drugs that ease these symptoms, they become less effective as the disease progresses. One of the hallmarks of the condition is deposits of insoluble fibres of a substance called synuclein. Normally found as small soluble molecules in healthy nerve cells, in people with Parkinson’s, something causes the synuclein molecules to warp into a different shape, making them clump together as fibres. The first clue that this transition may start outside the brain came about a decade ago, when pathologists reported seeing the distinctive synuclein fibres in nerves of the gut during autopsies – both in people with Parkinson’s and in those without symptoms but who had the fibres in their brain. They suggested the trigger was some unknown microbe or toxin. © Copyright Reed Business Information Ltd.

Keyword: Parkinsons
Link ID: 22938 - Posted: 12.01.2016

Amanda Gefter As we go about our daily lives, we tend to assume that our perceptions—sights, sounds, textures, tastes—are an accurate portrayal of the real world. Sure, when we stop and think about it—or when we find ourselves fooled by a perceptual illusion—we realize with a jolt that what we perceive is never the world directly, but rather our brain’s best guess at what that world is like, a kind of internal simulation of an external reality. Still, we bank on the fact that our simulation is a reasonably decent one. If it wasn’t, wouldn’t evolution have weeded us out by now? The true reality might be forever beyond our reach, but surely our senses give us at least an inkling of what it’s really like. Not so, says Donald D. Hoffman, a professor of cognitive science at the University of California, Irvine. Hoffman has spent the past three decades studying perception, artificial intelligence, evolutionary game theory and the brain, and his conclusion is a dramatic one: The world presented to us by our perceptions is nothing like reality. What’s more, he says, we have evolution itself to thank for this magnificent illusion, as it maximizes evolutionary fitness by driving truth to extinction. Getting at questions about the nature of reality, and disentangling the observer from the observed, is an endeavor that straddles the boundaries of neuroscience and fundamental physics. On one side you’ll find researchers scratching their chins raw trying to understand how a three-pound lump of gray matter obeying nothing more than the ordinary laws of physics can give rise to first-person conscious experience. This is the aptly named “hard problem.”

Keyword: Consciousness
Link ID: 22937 - Posted: 12.01.2016

By Clare Wilson Could a brain stimulation device change our sex drive? The first study of this approach suggests that people’s libido can be turned up or down, depending on the device’s setting. The study didn’t measure how much sex people had in real life, instead it measured participant’s sexual responsiveness. Unusually, this was done by fixing customised vibrators to people’s genitals and gauging how their brainwaves changed when they expected a stimulating buzz. “You want to see if they want what you’re offering,” says Nicole Prause at the University of California, Los Angeles. “This is a good model for sexual desire.” The technique involves transcranial magnetic stimulation (TMS), where a paddle held above the head uses a strong magnetic field to alter brain activity. It can be used to treat depression and migraines, and is being investigated for other uses, including preventing bed-wetting, and helping those with dyslexia. The part of the head targeted in this study – called the left dorsolateral prefrontal cortex, roughly above the left temple – is involved in the brain’s reward circuitry. © Copyright Reed Business Information Ltd.

Keyword: Sexual Behavior
Link ID: 22936 - Posted: 12.01.2016

Erika Check Hayden Physicians may soon have a lot more help in treating newborns. Neuroscientists and physicians have embarked on what they hope will be a revolution in treatments to prevent brain damage in newborn babies. As many as 800,000 babies die each year when blood and oxygen stop flowing to the brain around the time of birth. And thousands develop brain damage that causes long-lasting mental or physical disabilities, such as cerebral palsy. Physicians have few tools to prevent this, but they are optimistic that clinical trials now under way will change things. The trials were sparked by neuroscientists’ realization in the 1990s that some brain injuries can be repaired. That discovery spurred a flurry of basic research that is just now coming to fruition in the clinic. In January, a US study will start to test whether the hormone erythropoietin, or EPO, can prevent brain damage hours after birth when combined with hypothermia, in which babies are cooled to 33.5 °C. A trial in Australia is already testing this treatment. Physicians in countries including the United States, China and Switzerland are testing EPO in premature babies, as well as other treatments, such as melatonin, xenon, argon, magnesium, allopurinol and cord blood in full-term babies. “The world has really changed for us,” says neurologist Janet Soul at Boston Children’s Hospital in Massachusetts. Therapeutic hypothermia was the first success: clinical trials over the past decade have shown that it decreases the risk of death and of major brain-development disorders by as much as 60%. It is now standard treatment for babies in developed countries whose brains are deprived of blood and oxygen during birth. © 2016 Macmillan Publishers Limited,

Keyword: Development of the Brain
Link ID: 22935 - Posted: 11.30.2016

Anya Kamenetz Brains, brains, brains. One thing we've learned at NPR Ed is that people are fascinated by brain research. And yet it can be hard to point to places where our education system is really making use of the latest neuroscience findings. But there is one happy nexus where research is meeting practice: bilingual education. "In the last 20 years or so, there's been a virtual explosion of research on bilingualism," says Judith Kroll, a professor at the University of California, Riverside. Again and again, researchers have found, "bilingualism is an experience that shapes our brain for a lifetime," in the words of Gigi Luk, an associate professor at Harvard's Graduate School of Education. At the same time, one of the hottest trends in public schooling is what's often called dual-language or two-way immersion programs. Traditional programs for English-language learners, or ELLs, focus on assimilating students into English as quickly as possible. Dual-language classrooms, by contrast, provide instruction across subjects to both English natives and English learners, in both English and in a target language. The goal is functional bilingualism and biliteracy for all students by middle school. New York City, North Carolina, Delaware, Utah, Oregon and Washington state are among the places expanding dual-language classrooms. © 2016 npr

Keyword: Language; Learning & Memory
Link ID: 22934 - Posted: 11.30.2016

By Andy Coghlan Don’t go to bed angry. Now there’s evidence for this proverb: it’s harder to suppress bad memories if you sleep on them. The discovery could reveal new ways to treat people who suffer from conditions like post-traumatic stress disorder, and reinforces an earlier idea that it is possible to suppress bad memories through sleep deprivation. “The results are of major interest for treating the frequent clinical problem of unwanted memories, memories of traumatic events being the most prominent example,” says Christoph Nissen at the University of Freiburg Medical Center in Germany, who was not involved in the work. In the study, 73 male students memorised 26 mugshots, each paired with a disturbing image, such as a mutilated body, corpse or crying child. The next day they were asked to recall the images associated with half the mugshots and actively try to exclude memories of the rest of the associated images. The group were then directed to memorise another 26 pairs of mugshots and nasty images. Half an hour later they again thought about half the associated images and actively suppressed memories of the rest. Finally, they were asked to describe the image associated with each of the 52 mugshots. The idea was to see if trying to suppress a bad memory works better before or after sleep. © Copyright Reed Business Information Ltd.

Keyword: Sleep; Learning & Memory
Link ID: 22933 - Posted: 11.30.2016

By DAVE PHILIPPS CHARLESTON, S.C. — After three tours in Iraq and Afghanistan, C. J. Hardin wound up hiding from the world in a backwoods cabin in North Carolina. Divorced, alcoholic and at times suicidal, he had tried almost all the accepted treatments for post-traumatic stress disorder: psychotherapy, group therapy and nearly a dozen different medications. “Nothing worked for me, so I put aside the idea that I could get better,” said Mr. Hardin, 37. “I just pretty much became a hermit in my cabin and never went out.” Then, in 2013, he joined a small drug trial testing whether PTSD could be treated with MDMA, the illegal party drug better known as Ecstasy. “It changed my life,” he said in a recent interview in the bright, airy living room of the suburban ranch house here, where he now lives while going to college and working as an airplane mechanic. “It allowed me to see my trauma without fear or hesitation and finally process things and move forward.” Based on promising results like Mr. Hardin’s, the Food and Drug Administration gave permission Tuesday for large-scale, Phase 3 clinical trials of the drug — a final step before the possible approval of Ecstasy as a prescription drug. If successful, the trials could turn an illicit street substance into a potent treatment for PTSD. Through a spokeswoman, the F.D.A. declined to comment, citing regulations that prohibit disclosing information about drugs that are being developed. © 2016 The New York Times Company

Keyword: Stress; Drug Abuse
Link ID: 22932 - Posted: 11.30.2016

By Melissa Dahl Considering its origin story, it’s not so surprising that hypnosis and serious medical science have often seemed at odds. The man typically credited with creating hypnosis, albeit in a rather primitive form, is Franz Mesmer, a doctor in 18th-century Vienna. (Mesmer, mesmerize. Get it?) Mesmer developed a general theory of disease he called “animal magnetism,” which held that every living thing carries within it an internal magnetic force, in liquid form. Illness arises when this fluid becomes blocked, and can be cured if it can be coaxed to flow again, or so Mesmer’s thinking went. To get that fluid flowing, as science journalist Jo Marchant describes in her recent book, Cure, Mesmer “simply waved his hands to direct it through his patients’ bodies” — the origin of those melodramatic hand motions that stage hypnotists use today.” After developing a substantial following — “mesmerism” became “the height of fashion” in late 1780s Paris, writes Marchant — Mesmer became the subject of what was essentially the world’s first clinical trial. King Louis XVI pulled together a team of the world’s top scientists, including Benjamin Franklin, who tested mesmerism and found its capacity to “cure” was, essentially, a placebo effect. “Not a shred of evidence exists for any fluid,” Franklin wrote. “The practice … is the art of increasing the imagination by degrees.” Maybe so. But that doesn’t mean it doesn’t work. © 2016, New York Media LLC.

Keyword: Attention; Pain & Touch
Link ID: 22931 - Posted: 11.30.2016

By David Grimm Animal research has a publication problem. About half of all animal experiments in academic labs, including those testing for cancer and heart drugs, are never published in scientific journals, and those that are have been notoriously hard to replicate. That’s part of the reason that most drugs that work in animals don’t work in people—only 11% of oncology compounds that show promise in mice are ever approved for humans—despite billions of dollars spent by pharmaceutical and biotech companies. Meanwhile, academic labs waste money, mice, and other resources on experiments that, unbeknownst to them, have already been done but were never reported. In response to similar concerns about human studies, the U.S Food and Drug Administration (FDA) in 2007 mandated that researchers conducting human clinical trials preregister the details in an online database like ClinicalTrials.gov. Now, some scientists are wondering whether a similar approach makes sense for animal experiments. In a study published this month in PLOS Biology, Daniel Strech, a bioethicist at Hannover Medical School in Germany, and colleagues investigated the idea of so-called animal study registries. They scoured the literature and interviewed nearly two dozen scientists to determine the pros and cons of such registries—and whether they would actually make a difference. Strech chatted with Science to discuss the group’s findings. This interview has been edited for clarity and length. Q: What would these registries look like? © 2016 American Association for the Advancement of Science

Keyword: Animal Rights
Link ID: 22930 - Posted: 11.30.2016

By NICHOLAS BAKALAR Stroke rates have been declining in older people over the past 20 years — but have sharply increased in those under 55. Researchers at Rutgers University used data from the New Jersey Department of Health on more than 227,000 hospitalizations for stroke from 1995 through 2014, calculating incidence by age over five-year periods. The findings appeared in the Journal of the American Heart Association. Compared with the 1995-99 period, the rate of stroke in 2010-14 increased by 147 percent in people 35 to 39, by 101 percent in people 40 to 44, by 68 percent in those 45 to 49, and by 23 percent in the 50 to 54 group. Stroke is still far more common in older people. But the rate decreased by 11 percent in those 55 to 59, by 22 percent in the 60 to 64 group, and by 18 percent in people 65 to 69. The reasons are unclear, but the lead author, Joel N. Swerdel, now an epidemiologist with Janssen Pharmaceuticals, said that increasing obesity and diabetes in younger people are probably involved. “For a person 30 to 50, the good news is you ain’t dead yet,” he said. “With behavioral changes, changing diet, increasing exercise, there’s still hope for you. Behavioral change is hard, but this study is an early warning sign.” © 2016 The New York Times Company

Keyword: Stroke
Link ID: 22929 - Posted: 11.30.2016

By Virginia Morell If you’ve ever watched ants, you’ve probably noticed their tendency to “kiss,” quickly pressing their mouths together in face-to-face encounters. That’s how they feed each other and their larvae. Now, scientists report that the insects are sharing much more than food. They are also communicating—talking via chemical cocktails designed to shape each other and the colonies they live in. The finding suggests that saliva exchange could play yet-undiscovered roles in many other animals, from birds to humans, says Adria LeBoeuf, an evolutionary biologist at the University of Lausanne in Switzerland, and the study’s lead author. “We’ve paid little attention to what besides direct nutrition is being transmitted” in ants or other species, adds Diana Wheeler, an evolutionary biologist at the University of Arizona in Tucson, who was not involved with the work. Social insects—like ants, bees, and wasps—have long been known to pass food to one another through mouth-to-mouth exchange, a behavior known as trophallaxis. They store liquid food in “social stomachs,” or crops, from which they can regurgitate it later. It’s how nutrients are passed from foraging ants to nurse ants, and from nurses to the larvae in a colony. Other research has suggested that ants also use trophallaxis to spread the colony’s odor, helping them identify their own nest mates. © 2016 American Association for the Advancement of Science

Keyword: Chemical Senses (Smell & Taste)
Link ID: 22928 - Posted: 11.29.2016

By John Horgan Asked for a comment on the language-acquisition theory of Noam Chomsky (in photo above), psychologist Steven Pinker says: “Chomsky has been a piñata, where anyone who finds some evidence that some aspect of language is learned (and there are plenty), or some grammatical phenomenon varies from language to language, claims to have slain the king. It has not been a scientifically productive debate, unfortunately.” Credit: Ministerio de Cultura de la Nación Argentina Flickr (CC BY-SA 2.0) Noam Chomsky’s political views attract so much attention that it’s easy to forget he’s a scientist, one of the most influential who ever lived. Beginning in the 1950s, Chomsky contended that all humans possess an innate capacity for language, activated in infancy by minimal environmental stimuli. He has elaborated and revised his theory of language acquisition ever since. Chomsky’s ideas have profoundly affected linguistics and mind-science in general. Critics attacked his theories from the get-go and are still attacking, paradoxically demonstrating his enduring dominance. Some attacks are silly. For example, in his new book A Kingdom of Speech Tom Wolfe asserts that both Darwin and “Noam Charisma” were wrong. (See journalist Charles Mann’s evisceration of Wolfe.) © 2016 Scientific American

Keyword: Language
Link ID: 22927 - Posted: 11.29.2016

By Sarah Kaplan I don't know if the holidays are as emotional for you as they are for me, but I have never been able to get through this season without shedding buckets of tears. Why do we cry in the first place? Does it actually do anything to make us feel better? Here's what science has to say: Girl, we feel you. (Or guy. Guys can cry, too. And psychologists say that emotional control probably isn't good for men. So go ahead and let it out.) Anyway. You shouldn't feel shame about shedding tears of emotion. Weeping is part of what makes you human. Although other animals may yelp or whimper in pain or fear, and many creatures have tear ducts in their eyes to help flush out dirt and irritants, humans are the only species known to cry for emotional reasons. And scientists aren't really sure why. One theory is that tears are a communication tool. Before they learn to speak, babies cry to get attention. They start out with tearless wails, but at around three or four months, they start to weep when upset as well. Evolutionary psychologists have argued that infants' tears are related to the distress vocalizations produced by other young animals: Crying conveys their need for parental care. It's also thought that a baby's crying has evolved to be especially evocative for parents — something few stressed-out, sleep-deprived parents of newborns would disagree with. This theory would explain the loud, chaotic tantrums thrown by children when hurt or distressed. But what about adult emotional tears, which are usually much quieter? In those cases, crying could be a method of “conspecific communication” — a way of alerting sympathetic neighbors that something is wrong, without attracting the attention of a predator. © 1996-2016 The Washington Post

Keyword: Emotions
Link ID: 22926 - Posted: 11.29.2016

Nancy Shute Getting the flu while pregnant doesn't appear to increase the child's risk of being diagnosed with autism later on, a study finds, and neither does getting a flu shot while pregnant. The study, published Tuesday in JAMA Pediatrics, tries to tease apart subtle questions of risk and risk avoidance. Some smaller, earlier studies have found an association between serious viral infections in pregnancy or maternal fever in pregnancy and increased autism risk. This much larger study finds no such ties, though the authors note that it shouldn't be the last word on the topic. This study examined the health records of 196,929 children who were born at Kaiser Permanente facilities in Northern California between 2000 and 2010. They found that 3,101 children, or 1.6 percent, had been diagnosed with autism through June 2015. The researchers then looked at the mothers' health records to see if they had been diagnosed with flu while pregnant and whether they'd gotten a flu shot. Less than 1 percent of women had the flu; about 23 percent got a flu shot while pregnant, a number that rose from 6 percent in 2000 to 58 percent in 2010. They found no correlation overall between having the flu while pregnant and increased autism risk in children. © 2016 npr

Keyword: Autism; Neuroimmunology
Link ID: 22925 - Posted: 11.29.2016

By Louisa J. Steinberg “You've got to be kidding me, Doc. I can barely keep my eyes open as it is, and you want me to pull an all-nighter?” I smiled. “Yes, exactly that. Maybe even two or three.” It started out benignly enough. Jodi (not the patient's real name) had been feeling more stressed between meeting the growing demands of her high-stakes job in business management and shouldering more chores while her husband was away on business trips. Strapped for time, she started neglecting her usual self-care routines—eating healthy, exercising, taking time to relax. Not surprisingly, her mood was poor. Things soon grew worse. She no longer enjoyed activities that were usually the highlight of her day: story time with her children, chatting on the phone with her mom, reading a book. Although she was constantly exhausted, she could not get a good night's sleep; she would toss and turn and still feel tired even when she slept in. Her performance at work had also been suffering; she began missing days because she just couldn't get out of bed. Jodi knows she should have recognized these warning signs sooner. She had experienced major depression twice before, once in college and again in her late 20s after a breakup. Now in her late 30s, she had been off antidepressants for years. Yet she found herself back in that dark place, barely eating and unable to concentrate enough to read even a short paragraph. Her thoughts circled around the same unpleasant memories and nagging fears. She felt hopeless and guilty. © 2016 Scientific American

Keyword: Depression; Sleep
Link ID: 22924 - Posted: 11.29.2016

By Smitha Mundasad Health reporter About 9,000 stroke patients a year are missing out on a treatment that can prevent disability following a stroke, say UK experts. Clot retrieval can restore blood flow to the brain, preventing some lasting damage, but currently only 600 patients a year get this therapy, they estimate. A national stroke audit reveals part of the problem is a lack of skilled staff to do the procedure. NHS England says stroke patients are receiving high quality care. During a stroke, the blood supplying vital parts of the brain is interrupted. The most common reason is a clot blocking a major blood vessel in the head, although some strokes are caused by a bleed. The longer a part of the brain is starved of blood, the more likely lasting damage - such as paralysis and speech problems - will occur. Expanding mesh While many people with a stroke caused by a clot currently get drugs to help dissolve the blockage, this does not always work completely. Thrombectomy - or clot retrieval - is another method, which aims to remove the clot mechanically. It is a highly skilled operation, and stroke services need to be set up to be able to deliver the treatment. A thin metal wire housing a mesh is inserted into a major artery in the leg and, under X-ray guidance, it is directed to the site of the problem in the brain. The mesh is then expanded, like a miniature fishing net, to trap and remove the clot. 'Once the clot was out, the damage stopped' © 2016 BBC

Keyword: Stroke
Link ID: 22923 - Posted: 11.29.2016

By Ben Andrew Henry As a graduate student in the field of olfactory neuroscience, conducting what his former mentor describes as ambitiously clever research, Jason Castro felt something was missing. “I wanted to use science to make a connection with people,” he says, not just to churn out results. In 2012, the 34-year-old Castro accepted a faculty position at Bates College, a small liberal arts school in Maine, in order to “do the science equivalent of running a mom-and-pop—a small operation, working closely with students, and staying close to the data and the experiments myself,” he says. Students who passed through his lab or his seminars recall Castro as a dedicated mentor. “He spent hours with me just teaching me how to code,” recalled Torben Noto, a former student who went on to earn a PhD in neuroscience. After he arrived at Bates, Castro, along with two computational scientists, enlisted big-data methodologies to search for the olfactory equivalent of primary colors: essential building blocks of the odors we perceive. Their results, based on a classic set of data in which thousands of participants described various odors, identify 10 basic odor categories.1 Castro launched another project a few months later, when a paper published in Science reported that humans could discriminate between at least a trillion different odors. A friend from grad school, Rick Gerkin, smelled something fishy about the findings and gave Castro a call. “We became obsessed with the topic,” says Gerkin, now at Arizona State University. The researchers spent almost two years pulling apart the statistical methods of the study, finding that little tweaks to parameters such as the number of test subjects created large swings in the final estimate—a sign that the results were not robust.2 This August, the original study’s authors published a correction in Science. © 1986-2016 The Scientist

Keyword: Chemical Senses (Smell & Taste)
Link ID: 22922 - Posted: 11.29.2016

By C. CLAIBORNE RAY Q. Is a night’s sleep physiologically beneficial even if it includes emotionally disturbing nightmares? A. Almost certainly yes, said Dr. Neomi Shah, a specialist at the Mount Sinai Integrative Sleep Center in New York. Despite the problems nightmares can cause, sleeping and having them is better than not sleeping, research suggests. Nightmares can make it difficult to sleep and interfere with daytime functioning, but physiological indicators of sleep patterns and quality do not differ in people who have nightmares, Dr. Shah said. Frequent long, distressing and vivid dreams often wake people and cause problems like insomnia and poor sleep quality, she said. Research has also consistently demonstrated that nightmares can harm general well-being, affect mood and elevate stress. Some studies suggest there are measurable sleep problems for people who have nightmares, while others show no difference. The studies that show such a link found that people who woke up stayed awake longer and that certain stages of sleep did not last as long. But people in those studies who had nightmares also had longer periods of rapid eye movement, or REM, sleep, when most dreaming occurs. A weakness of these studies is that they were not conducted in the subjects’ normal sleeping environment. A more recent study in such an environment found no differences in so-called sleep architecture, sleep-cycle and REM durations, or sleep patterns for just the nights with nightmares. © 2016 The New York Times Company

Keyword: Sleep
Link ID: 22921 - Posted: 11.29.2016